Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Opyl Ltd. ( (AU:PKY) ) is now available.
Pathkey.AI Ltd has successfully completed a A$2.5 million placement and launched a A$0.98 million rights issue to accelerate its AI growth strategy. The funds will be used to enhance the company’s AI engine, scale commercial activities, and explore strategic growth opportunities. The company also announced governance changes, including the appointment of Shannon Robinson as Non-Executive Chair and the transition of Damon Rasheed to Executive Director, to support its next phase of growth.
More about Opyl Ltd.
Pathkey.AI Ltd is a leader in AI-driven clinical trial optimization, focusing on enhancing its core AI engine and TrialKey platform. The company is involved in scaling commercial activities across clinical trials and adjacent verticals, and exploring strategic growth opportunities, including potential acquisitions in the AI sector.
Average Trading Volume: 1,115,141
Technical Sentiment Signal: Sell
Current Market Cap: A$4.84M
For an in-depth examination of PKY stock, go to TipRanks’ Overview page.